QA: Aptinyx Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001674365_2023_Aptinyx_Inc.pdf

Logs

Graph

Absolute values for 0001674365, Aptinyx Inc.

  xvar xval
0 AssetsCurrent 64,030,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 32,000
3 remainder_Assets 2,622,000
4 LiabilitiesCurrent 6,291,000
5 LiabilitiesNoncurrent 22,108,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,819,000
9 ResearchAndDevelopmentExpense 42,748,000
10 remainder_Expenses 3,019,000
11 remainder_Revenues 0
12 remainder_NetIncome 737,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 66,684,000
1 Liabilities 28,399,000
2 Expenses 65,586,000
3 Revenues 0
4 StockholdersEquity 38,285,000
5 NetIncome -64,849,000
6 ComprehensiveNetIncome -64,849,000
7 BaseVar 80,703,000
8 EconomicCapitalRatio 0.0211

Edgar->Model Mapping

Feature Distribution

Change over Time